惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

B
Blog RSS Feed
量子位
Y
Y Combinator Blog
大猫的无限游戏
大猫的无限游戏
B
Blog
U
Unit 42
C
Check Point Blog
I
InfoQ
aimingoo的专栏
aimingoo的专栏
雷峰网
雷峰网
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
博客园 - 【当耐特】
人人都是产品经理
人人都是产品经理
The Cloudflare Blog
H
Help Net Security
MongoDB | Blog
MongoDB | Blog
博客园 - Franky
H
Hackread – Cybersecurity News, Data Breaches, AI and More
J
Java Code Geeks
Microsoft Azure Blog
Microsoft Azure Blog
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
云风的 BLOG
云风的 BLOG
宝玉的分享
宝玉的分享
爱范儿
爱范儿

Ars Technica

Microsoft issues emergency update for macOS and Linux ASP.NET threat Anthropic tested removing Claude Code from the Pro plan Coyote vs. Acme is finally getting released—with a killer trailer Google unveils two new TPUs designed for the "agentic era" Tabloid reports linking 10 missing and dead scientists spur FBI probe Physicists think they've solved the muon mystery New court ruling blocks many of the government's anti-renewable policies Indian med student rakes in thousands with AI-generated MAGA hottie As EV batteries improve, ChargePoint debuts 600 kW fast charger Our favorite gear at Sea Otter Classic wasn't the bikes—it was the accessories Investors lost billions on Trump’s memecoin. Another gala won’t fix that. Pentagon wants $54B for drones, more than most nations’ military budgets Mozilla: Anthropic's Mythos found 271 security vulnerabilities in Firefox 150 Supreme Court arguments make it clear that FCC fines are "nonbinding" Silo S3 teaser hints at the wasteland's origins Framework's CEO on the RAM crisis and creating a "MacBook Pro for Linux users" Florida probes ChatGPT role in mass shooting. OpenAI says bot "not responsible." Report: Meta will train AI agents by tracking employees' mouse, keyboard use Microsoft removes Call of Duty from Game Pass, lowers subscription pricing Framework Laptop 13 Pro is a major overhaul for the modular, upgradeable laptop Framework Laptop 16 upgrades make it look less like an unfinished prototype Internal emails show how Amazon raises prices across the Internet, lawsuit says Anthropic gets $5B investment from Amazon, will use it to buy Amazon chips CATL's new LFP battery can charge from 10 to 98% in less than 7 minutes AMD Ryzen 9 9950X3D2 Dual Edition review: Tons of cache for tons of dollars What's the deal with spacesuits for the Moon? Will they be ready in time? Loneliness in older adults can often lead to memory impairment Contrary to popular superstition, AES 128 is just fine in a post-quantum world Pentagon pulls the plug on one of the military's most troubled space programs John Ternus will replace Tim Cook as Apple CEO
Man dies covered in necrotic lesions after amoebas eat hi...
Beth Mole · 2026-05-02 · via Ars Technica

Of all the known ways to get an Acanthamoeba infection, nasal rinsing was the most likely one in the man’s case. The man had nasal polyps and used sinus rinses to alleviate his symptoms. However, his symptoms didn’t start in his nasal passages—they started on his legs. There, red nodules formed and progressed to develop dark centers. Some became deep ulcers, while others became necrotic, turning to black scabs. They then began erupting on his trunk, arms, and neck.

Catching a killer

Before his transfer to Yale, doctors elsewhere tried to identify the mysterious cause, doing multiple biopsies of his diseased skin. Tests were negative for bacterial or fungal pathogens. But they showed his blood vessels were inflamed and full of clumps of immune cells. Doctors worried that his immune system was attacking his blood vessels, causing the necrotic lesions. So, they put him on immunosuppressant drugs. But his condition only worsened, and the lesions only progressed. When he arrived at Yale, he had a fever and high heart rate, and appeared frail. He had lost 16 pounds and was drowsy and confused. He was blanketed in lesions.

The Yale doctors noted that the lesions began after he returned from Florida, where he spent the winters. While there, he was exposed to a red tide (caused by algae) while cleaning up after a hurricane. Otherwise, he had a medical history of just the nasal polyps and asthma, which he treated with a monoclonal antibody drug, dupilumab. Given that his lesions progressed, they redid a skin biopsy, this time finding cells that looked like amoebas. DNA testing confirmed Acanthamoeba.

The doctors quickly put him on a five-drug regimen recommended for such infections by the Centers for Disease Control and Prevention, but he continued to deteriorate. They then sought and got approval from the Food and Drug Administration for a single-patient experimental trial of an antibiotic (nitroxoline) that had shown success in treating a different amoeba in another patient. Once the doctors started it in the man, it appeared to work. His fever broke briefly, some of his lesions improved, and no new ones formed.